An Act to renumber and amend 49.485; to amend 801.02 (1), 803.09 (1), 803.09 (2), 804.01 (2) (intro.) and 805.04 (1); to create 20.9315, 49.485 (1), 165.25 (11m), 805.04 (2p) and 893.9815 of the statutes; Relating to: restoring private individual authority to bring a qui tam claim against a person for making a false claim for medical assistance, actions by the attorney general against a person for making a false claim for medical assistance, and providing a penalty. (FE)
AB1237 would restore and expand Wisconsin’s ability to pursue false-claims cases involving Medical Assistance (Medicaid) by allowing private individuals to file qui tam actions on behalf of the state, a remedy that was removed in 2015 Wisconsin Act 55. The bill creates a new statutory section governing these cases, defines key terms such as “claim,” “knowingly,” and “material,” and sets out procedures for filing under seal, attorney general review, state intervention, discovery stays, settlement approval, and dismissal rules. It also authorizes whistleblower-style awards for successful relators, including a share of recovered proceeds, expenses, and attorney fees, and adds retaliation protections for employees, contractors, and agents who assist in reporting or prosecuting false claims.
The bill also updates the existing false-claims penalty statute for medical assistance to align more closely with the federal False Claims Act. It expands liability to include false records or statements, false obligations, and conspiracy, and ties forfeiture amounts to federal ranges rather than the current fixed dollar amounts. In addition, it gives the Department of Justice and the attorney general parallel authority to pursue claims directly or through alternate remedies, including administrative proceedings, and establishes a 10-year limitations period for actions under the new section. The bill amends civil procedure statutes to account for sealed qui tam filings, limits intervention and dismissal rules in these cases, and makes criminal fraud convictions preclusive in related civil actions.
The overall sentiment reflected in the bill materials is policy-driven and enforcement-oriented rather than partisan or contentious in the available record. The bill was introduced with bipartisan cosponsorship and framed as a restoration and modernization of anti-fraud tools for the Medical Assistance program. However, the measure ultimately failed to pass, indicating that it did not secure the necessary legislative support despite its stated goal of strengthening fraud recovery and aligning state law with federal standards.
The main point of contention is the return of private qui tam enforcement in Medicaid-related fraud cases. Supporters would likely view the bill as expanding fraud detection, increasing recoveries, and protecting whistleblowers, while opponents may be concerned about increased litigation, relator incentives, expanded attorney general authority, and the burden on providers or other program participants. The bill also raises procedural concerns by limiting intervention, sealing complaints, restricting dismissal, and extending the statute of limitations, all of which shift the balance toward enforcement and away from early public disclosure or defendant control over the litigation process.
AB1237 would substantially revise Wisconsin’s Medical Assistance false-claims enforcement framework by creating a new state qui tam cause of action, expanding DOJ enforcement tools, and conforming key liability and penalty provisions to the federal False Claims Act. It would amend civil procedure statutes to accommodate sealed whistleblower filings and special dismissal/intervention rules, and it would create a 10-year limitations period for these claims. The bill would directly affect Medicaid providers, contractors, employees, whistleblowers, the Department of Justice, and courts handling fraud litigation.
The available materials suggest generally favorable policy intent around combating fraud in the Medical Assistance program, with the bill presented as a restoration of a previously available enforcement mechanism and a modernization of state law. The introduction included bipartisan cosponsors, which suggests some cross-party interest in the concept. At the same time, the bill did not advance and ultimately failed to pass, indicating that support was insufficient to overcome concerns about the scope and consequences of reviving qui tam litigation.
The central controversy is whether private individuals should again be allowed to sue on the state’s behalf over false Medical Assistance claims. Supporters are likely to emphasize stronger fraud detection, whistleblower incentives, and higher recoveries for the state, while critics may object to increased litigation exposure, expanded penalties, and the possibility of opportunistic or duplicative lawsuits. Additional contentious provisions include the bill’s limits on dismissal and intervention, its sealing requirements, its broad alignment with federal False Claims Act standards, and its extended 10-year filing window.